Enhance your paramedic skills with the Platinum Paramedic Test. Dive into comprehensive quiz formats with detailed explanations and solutions. Prepare effectively for your certification!

Multiple Choice

What is the first-line pharmacologic treatment for wheezing in an infant?

In infants with acute wheeze, the priority is to rapidly relieve reversible airway obstruction by bronchodilation. An inhaled short-acting beta-agonist, such as albuterol, provides quick relief by relaxing bronchial smooth muscle, lowering airway resistance, and improving airflow. This rapid action makes it the first-line pharmacologic treatment for wheezing in an infant, whether the cause is bronchiolitis with episodic wheeze or early reactive airway disease. Epinephrine given intramuscularly is reserved for more life-threatening or specific airway situations (like severe croup or anaphylaxis) and is not the standard first-line treatment for typical infant wheeze. Diphenhydramine, an antihistamine, does not address bronchospasm and is not effective for acute wheezing. Prednisone is a systemic steroid used for certain asthma exacerbations or longer-term management, not as the initial acute therapy for wheeze in an infant.

In infants with acute wheeze, the priority is to rapidly relieve reversible airway obstruction by bronchodilation. An inhaled short-acting beta-agonist, such as albuterol, provides quick relief by relaxing bronchial smooth muscle, lowering airway resistance, and improving airflow. This rapid action makes it the first-line pharmacologic treatment for wheezing in an infant, whether the cause is bronchiolitis with episodic wheeze or early reactive airway disease.

Epinephrine given intramuscularly is reserved for more life-threatening or specific airway situations (like severe croup or anaphylaxis) and is not the standard first-line treatment for typical infant wheeze. Diphenhydramine, an antihistamine, does not address bronchospasm and is not effective for acute wheezing. Prednisone is a systemic steroid used for certain asthma exacerbations or longer-term management, not as the initial acute therapy for wheeze in an infant.